Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Caseys General Stores Anticipates Growth Through Expansion Strategy

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
DrugRetailers Stock Market Today
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Casey’s General Stores is anticipating a 3.5%-5% increase in same-store inside sales for fiscal year 2024, aligning with their long-term strategic plan’s goal of 8%-10% EBITDA growth. In the third quarter of the fiscal year, inside same-store sales saw a 4.1% increase compared to the previous year, boasting an inside margin of 41.3%. Despite reporting a diluted EPS of $2.33, a 13% decrease from the same period last year, and a net income of $87 million, also down 13%, Casey’s remains optimistic about their growth. They plan to open over 150 new stores in fiscal year 2024 and have expanded into their 17th state, Texas, as part of their expansion strategy.

Caseys General Stores Inc. (CASY) Stock Dips Slightly on March 11, 2024: What Investors Need to Know

On March 11, 2024, Casey’s General Stores Inc. (CASY) experienced a slight dip in its stock performance. CASY closed at $298.76, showing a decrease of $3.42 or 1.13% since the previous market close. Despite the slight decrease on March 11, CASY’s overall performance has been relatively strong, trading near the top of its 52-week range. Investors may want to keep an eye on any further developments or announcements from the company that could impact its stock price. Consulting with a financial advisor or analyst can help provide valuable insights and guidance in navigating the stock market.

CASY Stock Performance Analysis: Positive Growth in Total Revenue and Net Income

On March 11, 2024, CASY stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $15.09 billion for the past year, representing a 16.54% increase compared to the previous year. Additionally, the total revenue for the second quarter was $4.06 billion, showing a 5.04% increase from the previous quarter. In terms of net income, CASY reported a net income of $446.69 million for the past year, indicating a 31.46% increase from the previous year. However, the net income for the second quarter was $158.78 million, reflecting a 6.18% decrease from the previous quarter. Earnings per share (EPS) for CASY were $11.91 for the past year, showing a 30.89% increase compared to the previous year. On the other hand, the EPS for the second quarter was $4.24, demonstrating a 6.12% decrease from the previous quarter. Overall, CASY stock showed positive growth in total revenue and net income compared to the previous year. However, there was a slight decrease in net income and EPS from the previous quarter. Investors may want to closely monitor these financial metrics to assess the company’s performance and make informed investment decisions.

Tags: CASY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Alternative Energy Markets and money

NextDecade Corporations Strategic Growth and Construction Update

Biotechnology Stock Market Today (1)

Gartner Inc A Case Study in LongTerm Investment Success

Finance_Cash

Investors Monitor First Solar Price Target and Options Trading Activity

Recommended

Warner Bros. Discovery (A) Stock

Acquisition Battle Intensifies for Warner Bros. Discovery

3 months ago
Reviva Pharmaceuticals Holdings Stock

Reviva Pharmaceuticals Stock Surges on Extraordinary Trading Activity

4 months ago
MMM stock news

Analyst Insights and Price Targets for BILL Holdings

2 years ago
IonQ Stock

IonQ Shares Experience Technical Breakthrough Amid Market Correction

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Trending

Chicago Atlantic Real Estate Finance Stock
Analysis

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

by SiterGedge
February 8, 2026
0

Investors in Chicago Atlantic Real Estate Finance have received welcome clarification regarding the tax treatment of the...

RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

February 8, 2026
DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic
  • RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review
  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com